February 21st, 2018 by admin
August 24, 2016
PuraCap brings new Eptex Acne Skincare Products to market through Symplmed and DyrctAxess™ Technology
SOUTH PLAINFIELD, NJ – August 24, 2016 – PuraCap Pharmaceuticals announced today their new — product Eptex®. The Eptex Acne Treatment line is pharmaceutical grade acne treatment utilizing cutting-edge delivery systems and proven ingredients to effectively treat acne for patients with sensitive skin. Eptex is now available for direct ordering through the Physician Direct Order portal.
The Physician Direct program, powered by Symplmed’s patented DyrctAxess™ technology, provides Physician's a simple and secure method to order PuraCap products online and have them delivered directly to their office. The new Eptex line is the third product available through our partnership with Symplmed. PuraCap will continue to add products to Symplmed’s DyrctAxess™ technology, as they are introduced.
“We are pleased to continue growing our partnership with PuraCap and improving physician and patient availability to their array of dermatology products”, said Erik Emerson, CEO of Symplmed. “The physician direct order portal has been extremely well received, and we look forward to expanding on this technology platform to bring new opportunities in patient access.”
About Symplmed Technologies LLC
Symplmed Technologies is a private medical company improving the way manufacturers market, sell and distribute medical products by providing them directly to physicians, patients and care providers. Our patented technology platform, DyrctAxess™, enables direct order and delivery of our partner’s medications, eliminating issues of unfilled prescriptions while having a positive impact on compliance and outcomes. DyrctAxess further advances care by providing patients and doctors shared access to real-time information about medication use and its efficacy to help optimize care. For more information, visit www.symplmed.com.
About PuraCap Pharmaceutical LLC
PuraCap Pharmaceutical LLC is an emerging, fully integrated pharmaceutical company with expertise in product development, manufacturing and distribution, bringing high quality products & services to their customers. PuraCap’s corporate structure supports a two-pronged approach for global growth in the areas of prescription brands (PuraCap Pharmaceutical LLC) as well as prescription generics and OTC and private label brands (PuraCap Laboratories). Go to www.puracap.com for more information.
All of the statements contained in this news release, other than statements of fact that are independently verifiable at the date hereof, are forward-looking statements. Such statements, based as they are on the current expectations of management, inherently involve numerous risks and uncertainties, known and unknown. Some examples of known risks are: the impact of general economic conditions, general conditions in the pharmaceutical industry, changes in the regulatory environment in the jurisdictions in which Symplmed does business, fluctuations in costs, and changes to the competitive environment due to consolidation or otherwise. Consequently, actual future results may differ materially from the anticipated results expressed in the forward-looking statements.
Our patented technology platform, DataDirect™, enables direct order and delivery of medications...Learn More
Founded in pharma, we are well-equipped with the experience to grow your brand...Learn More
BioMauris leverages technology and direct-to-physician marketing to improve upon both the patient and provider...Learn More
At BioMauris we believe in building partnerships, which is why our programs are based on a gain-share model. By tying our success to yours, our partners enjoy the peace of mind that our team is constantly going above and beyond to find ways to improve upon your program. Benefits of starting a partnership with BioMauris include: